[Special Stock] Samsung Biologics Surges on Q3 Earnings Surprise
[Asia Economy Reporter Song Hwajeong] Samsung Biologics' stock price is strong following its robust performance in the third quarter of this year.
As of 10:33 AM on the 27th, Samsung Biologics was trading at 899,000 KRW, up 20,000 KRW (2.28%) from the previous day.
Hot Picks Today
!["Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③](https://cwcontent.asiae.co.kr/asiaresize/93/2026051422512663865_1778766774.jpg)
"Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The surprise earnings in the third quarter appear to have driven the stock price increase. Samsung Biologics' third-quarter results significantly exceeded expectations. The company announced that its consolidated sales for the third quarter reached 450.733 billion KRW, and operating profit was 167.411 billion KRW. These figures represent increases of 64.15% and 196.12%, respectively, compared to the same period last year. This marks the second consecutive quarter of record quarterly performance. Market consensus estimates were also surpassed by 9.6% and 26%, respectively.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
